PHARMACOKINETICS, BIO-EQUIVALENCE AND TISSUE RESIDUES OF TWO ORAL COLISTIN FORMULATIONS IN BROILER CHICKENS
Journal Title: International Journal of Pharmacy and Pharmaceutical Sciences - Year 2016, Vol 8, Issue 4
Abstract
Objective: The present study was carried out to investigate and provide an overview of the pharmacokinetics, bio-equivalence and tissue residues of colistin in two oral tested products, BAC-Liquido® (Interchemi Co.) and Coline-L® (Medmac Co.) in healthy broiler chickens.Methods: The comparative pharmacokinetics, bio-equivalence, blood and tissue residues of BAC-Liquido® and Coline-L® in broiler chickens was studied after oral administration of both products in a dose of 100.000 IU colistin base/kg. b. wt once daily for 5 consecutive days.Results: Colistin in both products obeyed a two compartments open model following I. V administration. The disposition kinetics of BAC-Liquido® and Coline-L® following oral administration of 100.000 IU colistin base/kg. b. wt revealed that the maximum blood concentration [Cmax.] were 5.10 and 4.95 µg/ml and attained at [tmax.] of 5.90 and 6.40 h, respectively. Colistin in BAC-Liquido® and Coline-L® was eliminated with half-lives [t1/2β] equal to 3.15 and 2.89 h, respectively. The mean systemic bioavailability of colistin in BAC-Liquido® and Coline-L® following oral administration in healthy chickens was 3.75 and 4.05%, respectively. The blood (µg/ml) and tissue (µg/g) residues of Coline-L® and BAC-Liquido® following repeated oral administrations showed that liver, kidney; lung, breast, and thigh muscles contained the limited colistin residues. Colistin in both preparations was completely disappeared from all tissues at 24 h following the last oral dose (except liver 48 h).Conclusion: It was concluded that Coline-L® is bioequivalent to BAC-Liquido® since Cmax test/Cmax reference and AUCtest/AUCreference ratios were 0.97 and 1.06, respectively. Chickens should not be slaughtered for human consumption within treatment and could be consumed after the discontinuation of the treatment (except liver, withdrawal time 48 h) of either BAC-Liquido® or Coline-L®.Keywords: Pharmacokinetics, Colistin, Broiler chickens, Bioavailability, Tissue residue.
Authors and Affiliations
Ahmed M. Soliman, Ahmed Ragab Elbestawy, Sherin Ibrahim
Keywords
Related Articles
- EP ID EP577710
- DOI -
- Views 51
- Downloads 0
HEALING POTENCY OF HAEMATOCOCCUS PLUVIALIS EXTRACT FOR TREATING TYPE 2 DIABETES IN RATS
Objective: The present study aims to evaluate the antidiabetic effect of ethanolic extract of Haematococcus pluvialis (H. pluvialis) in streptozotocin (STZ)-induced diabetic rats.Methods: The antidiabetic activity of H....
EFFECT OF HEPTOPLUS ON ISONIAZID AND RIFAMPICIN INDUCED HEPATOTOXICITY IN LIVER CELL LINES
Objective: To evaluate the hepato protective role of Heptoplus (HP), a ployherbal formulation as a supplementary agent for the Isoniazid and Rifampicin induced oxidative stress and apoptosis in liver. Methods: Liver cell...
PREVALENT RISK FACTORS OF HCV TRANSMISSION IN HEALTH CARE WORKERS (HCWS) IN PAKISTAN
Objective: To study and analyze the prevalent risk factors of Hepatitis C Virus (HCV) transmission in Health Care Workers (HCWs) in PakistanMethods: A literature survey (2005-2012) was conducted from the available litera...
DETERMINATION OF ANTIBACTERIAL, ANTIFUNGAL, BIOACTIVE CONSTITUENTS OF TRIPHALA BY FT-IR AND GC-MS ANALYSIS
Objectives: To characterize the number of phytoconstituents present in triphala using FT-IR and GC-MS.Methods: Antibacterial activity was measured by disc diffusion method, antifungal activity were analyzed by poisoned f...
IN VITRO ANTIBACTERIAL ACTIVITY OF KAEMPFERIA PANDURATA ROXB. AND CURCUMA XANTHORRHIZA ROXB. EXTRACTS IN COMBINATION WITH CERTAIN ANTIBIOTICS AGAINST MSSA AND MRSA
Objective: The aim of this study was to find an alternative treatment of MRSA infection. We evaluated the interaction of in vitro antibacterial activity of Kaempferia pandurata Roxb. (rhizome) or Curcuma xanthorrhiza Rox...